Frontiers in Immunology · 2014 · 22 citations · 44 references
Life SciencesImmunologyInfectious DiseasesAdaptive ImmunityClinical ImmunologyImmunology Of Infectious DiseasesAdaptive Immune ResponsesAntibody-mediated ProtectionAntiviral ImmunityHumoral ImmunityImmunological MemoryProtective ImmunityAntibody Specificity AnalysisCross-reactive AntigensCross-reactive ImmunityCross-reactive Immunological MemoryHumoral Immune MemoryPolyclonal AntibodiesProtective Immunological MemorySerotype-specific Immunity
Dengue virus has four serotypes and is endemic globally in tropical countries. Neither a specific treatment nor an approved vaccine is available, and correlates of protection are not established. The standard neutralization assay cannot differentiate between serotype-specific and serotype cross-reactive antibodies in patients early after infection, leading to an overestimation of the long-term serotype-specific protection of an antibody response. It is known that the cross-reactive response in patients is temporary but few studies have assessed kinetics and potential changes in serum antibody specificity over time. To better define the specificity of polyclonal antibodies during disease and after recovery, longitudinal samples from patients with primary or secondary DENV-2 infection were collected over a period of 1 year. We found that serotype cross-reactive antibodies peaked 3 weeks after infection and subsided within 1 year. Since secondary patients rapidly produced antibodies specific for the virus envelope (E) protein, an E-specific ELISA was superior compared to a virus particle-specific ELISA to identify patients with secondary infections. Dengue infection triggered a massive activation and mobilization of both naïve and memory B cells possibly from lymphoid organs into the blood, providing an explanation for the surge of circulating plasmablasts and the increase in cross-reactive E protein-specific antibodies.
44
Richard Kühn, Wei Zhang, Michael G. Rossmann et al. · Cell · 2002 · 1.6K citations · Full text
Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Wanwisa Dejnirattisai, Amonrat Jumnainsong, Naruthai Onsirisakul et al. · Science · 2010 · 940 citations
Martina Beltramello, Katherine L. Williams, Cameron P. Simmons et al. · Cell Host & Microbe · 2010 · 597 citations · Full text